ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AZ and ICL link to research respiratory diseases
pharmatimes
December 25, 2017AstraZeneca and Imperial College London have announced plans to work together on investigating the scientific mechanisms and underlying drivers of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Pharma Sources Insight January 2025
